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A B S T R A C T
Background
Visual problems in older people are common and frequently under-reported. The effects of poor vision in older people are wide reaching
and include falls, confusion and reduced quality of life.Much of the visual impairment in older ages can be treated (e.g. cataract surgery,
correction of refractive error). Vision screening may therefore reduce the number of older people living with sight loss.
Objectives
The objective of this review was to assess the effects on vision of community vision screening of older people for visual impairment.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials
Register) (2017, Issue 10); Ovid MEDLINE; Ovid Embase; the ISRCTN registry; ClinicalTrials.gov and the ICTRP. The date of the
search was 23 November 2017.
Selection criteria
We included randomised controlled trials (RCTs) that compared vision screening alone or as part of a multi-component screening
package as compared to no vision screening or standard care, on the vision of people aged 65 years or over in a community setting. We
included trials that used self-reported visual problems or visual acuity testing as the screening tool.
Data collection and analysis
We used standard methods expected by Cochrane. We graded the certainty of the evidence using GRADE.
Main results
Visual outcome data were available for 10,608 people in 10 trials. Four trials took place in the UK, two in Australia, two in the United
States and two in the Netherlands. Length of follow-up ranged from one to five years. Three of these studies were cluster-randomised
trials whereby general practitioners or family physicians were randomly allocated to undertake vision screening or no vision screening.
All studies were funded by government agencies. Overall we judged the studies to be at low risk of bias and only downgraded the
certainty of the evidence (GRADE) for imprecision.
Seven trials compared vision screening as part of a multi-component screening versus no screening. Six of these studies used self-
reported vision as both screening tool and outcome measure, but did not directly measure vision. One study used a combination of self-
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reported vision and visual acuity measurement: participants reporting vision problems at screening were treated by the attending doctor,
referred to an eye care specialist or given information about resources that were available to assist with poor vision. There was a similar
risk of “not seeing well” at follow-up in people screened compared with people not screened in meta-analysis of six studies (risk ratio
(RR) 1.05, 95% confidence interval (CI) 0.97 to 1.14, 4522 participants high-certainty evidence). One trial reported “improvement
in vision” and this occurred slightly less frequently in the screened group (RR 0.85, 95% CI 0.52 to 1.40, 230 participants, moderate-
certainty evidence).
Two trials compared vision screening (visual acuity testing) alone with no vision screening. In one study, distance visual acuity was
similar in the two groups at follow-up (mean difference (MD) 0.02 logMAR, 95% CI −0.02 to 0.05, 532 participants, high-certainty
evidence). There was also little difference in near acuity (MD 0.02 logMAR, 95% CI −0.03 to 0.07, 532 participants, high-certainty
evidence). There was no evidence of any important difference in quality of life (MD −0.06 National Eye Institute 25-item visual
function questionnaire (VFQ-25) score adjusted for baseline VFQ-25 score, 95% CI −2.3 to 1.1, 532 participants, high-certainty
evidence). The other study could not be included in the data analysis as the number of participants in each of the arms at follow-up
could not be determined. However the authors stated that there was no significant difference in mean visual acuity in participants who
had visual acuity assessed at baseline (39 letters) as compared to those who did not have their visual acuity assessed (35 letters, P = 0.25,
121 participants).
One trial compared a detailed health assessment including measurement of visual acuity (intervention) with a brief health assessment
including one question about vision (standard care). People given the detailed health assessment had a similar risk of visual impairment
(visual acuity worse than 6/18 in either eye) at follow-up compared with people given the brief assessment (RR 1.07, 95% CI 0.84 to
1.36, 1807 participants, moderate-certainty evidence). The mean composite score of the VFQ-25 was 86.0 in the group that underwent
visual acuity screening compared with 85.6 in the standard care group, a difference of 0.40 (95% CI −1.70 to 2.50, 1807 participants,
high-certainty evidence).
Authors’ conclusions
The evidence from RCTs undertaken to date does not support vision screening for older people living independently in a community
setting, whether in isolation or as part of a multi-component screening package. This is true for screening programmes involving
questions about visual problems, or direct measurements of visual acuity.
The most likely reason for this negative review is that the populations within the trials often did not take up the offered intervention as a
result of the vision screening and large proportions of those who did not have vision screening appeared to seek their own intervention.
Also, trials that use questions about vision have a lower sensitivity and specificity than formal visual acuity testing. Given the importance
of visual impairment among older people, further research into strategies to improve vision of older people is needed. The effectiveness
of an optimised primary care-based screening intervention that overcomes possible factors contributing to the observed lack of benefit in
trials to date warrants assessment; trials should consider including more dependent participants, rather than those living independently
in the community.
P L A I N L A N G U A G E S U M M A R Y
Community screening for visual impairment in older people
What was the aim of this review?
The aim of this review was to find out if community screening for visual impairment (sight loss) in older people results in improvements
in vision. Cochrane Review authors collected and analysed all relevant studies to answer this question and found 10 studies.
Key message
There is no evidence that community screening for visual impairment in older people reduces the level of visual impairment in people
living independently in the community. Further research on the barriers to accessing care at older ages is needed, as well as research
investigating the effect of vision screening on more dependent populations of older people.
What was studied in the review?
Vision problems are common in older people and are associated with an increased chance of falls and lower quality of life. Many
older people have undiagnosed vision problems and therefore do not receive appropriate treatment. Community vision screening of
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older people could lead to improvements in vision by helping to find people with vision problems and putting them in contact with
appropriate health care services that can provide treatment for the vision problem. The screening may consist of simple questions about
vision (self-reported vision problems) or an eye test involving reading letters on a chart.
Cochrane Review authors wanted to find out if vision screening results in an improvement in vision in people over 65 years old.
What are the main results of the review?
Cochrane Review authors found 10 relevant studies. Four studies were from the United Kingdom, two studies from Australia, two
from the United States and two from the Netherlands. These studies compared vision screening with no vision screening in people of
65 years of age or older. People taking part in these studies were followed up for between one and five years. All studies were funded
by government agencies.
The review shows that:
• communities that had vision screening did not have improved vision, on average, compared with communities who did not receive
vision screening;
• it did not make a difference if vision problems were self-reported or identified by a vision test (reading letters on a chart);
• it did not make a difference if the vision screening was done by itself, or as part of a broader health assessment.
Cochrane Review authors assessed how certain the evidence was for each review finding. They looked for factors that can make the
evidence less certain, such as problems with the way the studies were done, very small studies, and inconsistent findings across studies.
They also looked for factors that can make the evidence more certain, including very large effects. They graded each finding as very
low certainty, low certainty, moderate certainty or high certainty. This review included mostly high-certainty evidence.
How up to date is this review?
Cochrane Review authors searched for studies that had been published up to 23 November 2017.
B A C K G R O U N D
Health services for older people are of increasing importance. In
promoting health for older people, in recent years there has been
a change in emphasis away from a medically-orientated approach
and towards an approach which focuses on the improvement of
functional ability and quality of life, often termed ’healthy aging’
(Andrews 2001; Rubenstein 1989; Swedish National Institute of
Public Health 2007; Williams 1993). Improving sensory function
is central to this approach.
A number of community surveys have demonstrated high levels of
undiagnosed and untreated visual impairment among older people
(Evans 2004; Klein 1991; Wormald 1992). A variety of adverse
factors have been reported in association with visual impairment
including: reduced functional status, social interaction and quality
of life; depression; and falls.
Multi-component assessment of older people was originally de-
veloped in the United Kingdom (Williamson 1964) and has been
introduced in many countries. Multi-component assessment aims
to determine an older person’s medical, social, psychological and
functional problems, and to form a plan for treatment and fol-
low-up. Most forms of this assessment include some attempt to
assess vision. While multi-component assessment has been shown
to produce some small overall benefits (Stuck 1993), exactly which
procedures within the assessment are effective and which are in-
effective is uncertain. Specific screening procedures for chronic
open-angle glaucoma or diabetic retinopathy have not been in-
cluded in trials or programmes of multi-component screening as-
sessments.
Although the aim of improving visual impairment is clearly to
produce improvements in other clinical outcomes, (such as im-
proved quality of life or a reduction in falls), any benefit arising
from vision assessment will necessarily be dependent on improved
vision. Similarly, while the aims of multi-component screening of
older people are broad, any benefit arising from the inclusion of a
vision component in the assessment will necessarily be dependent
on improved vision. Therefore, this review used improvement in
vision as the outcome measure of interest.
3Community screening for visual impairment in older people (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Since screening alone without subsequent intervention (e.g. glasses
prescription, or other treatment from an eye specialist) cannot be
expected to result in improvements in vision, we refer throughout
this review to ’screening’ being the intervention with implied sub-
sequent intervention.
O B J E C T I V E S
The objective of this review was to assess the effects on vision of
community vision screening of older people for visual impairment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised controlled trials (RCTs) of visual
screening alone or as part of multi-component screening in people
aged 65 years or over in a community setting.
Types of participants
Participants in the trials were people aged 65 years or over who
were not identified as belonging to a particular risk group.
Types of interventions
We included trials in which there was any attempt at population
screening for visual impairment in a community setting, either
vision alone or as part of a multi-component screening assessment.
Types of outcome measures
The outcome included was the degree of visual impairment in the
population at the end of the trial. Assessment of vision by any
method (questions about vision, measures of visual function or
use of an acuity chart) at least six months after the initial vision
screening assessment was included.
We excluded trials of multi-component screening that did not
consider the impact of screening on vision outcomes.
Search methods for identification of studies
Electronic searches
The Cochrane Eyes and Vision Information Specialist conducted
systematic searches in the following databases for randomised con-
trolled trials and controlled clinical trials. There were no language
or publication year restrictions. The date of the search was 23
November 2017.
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 10) (which contains the Cochrane Eyes
and Vision Trials Register) in the Cochrane Library (searched 23
November 2017) (Appendix 1);
• MEDLINE Ovid (1946 to 23 November 2017) (Appendix
2);
• Embase Ovid (1980 to 23 November 2017) (Appendix 3);
• ISRCTN registry (www.isrctn.com/editAdvancedSearch;
searched 23 November 2017) (Appendix 4);
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov ( www.clinicaltrials.gov; searched 23
November 2017) (Appendix 5);
• World Health Organization ( WHO) International Clinical
Trials Registry Platform ( ICTRP) ( www.who.int/ictrp; searched
23 November 2017) (Appendix 6).
Searching other resources
We scanned the reference lists of identified trial reports and of
review articles for further relevant reports. We used the SciSearch
database to search for articles that cited the included studies. We
contacted the named author for correspondence for each of the
included trials to obtain information about any other trials.
Data collection and analysis
Selection of studies
Two authors independently assessed the titles and abstracts iden-
tified from the searches and obtained full reports of studies which
possibly or definitely fulfilled the selection criteria. A vision screen
may have beenonly one small part of amulti-component screening
programme and data about vision outcomes may not have been
included in published reports of trials. Therefore, we contacted
trial authors for further information about visual outcome data
if these were not reported. We also asked trial authors to provide
further details about the screening and outcome assessments and
about the interventions offered. We selected studies for which vi-
sion outcome data were available for quality assessment and data
extraction.
Data extraction and management
Two authors independently extracted data about visual outcomes
using paper data extraction sheets and entered data into Review
Manager 5 (RevMan 5) (Review Manager 2014). We resolved
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disagreements by discussion.The proportions of peoplewith visual
impairment in the experimental and control groups formed the
comparison.
For the cluster randomised studies we used effect estimates and
95% confidence intervals adjusted for the cluster design, where
these were reported by the study investigators. Where this was not
possible we did a sensitivity analysis reducing the effective sample
size by a design effect of 2 to see the extent the precision of the
effect estimate was affected by ignoring the cluster design.
Assessment of risk of bias in included studies
We assessed risk of bias based on the recommendations in Chap-
ter 8 of the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011).We considered the following parameters and
graded each parameter as low risk, unclear risk or high risk.
1. Sequence generation. We scored this as ’low risk’ if there
was some form of centralised randomisation scheme, an on-site
computer system or if sequentially-numbered sealed opaque
envelopes were used. We scored studies as ’unclear risk’ if
insufficient information was provided.
2. Allocation concealment. We graded this as ’low risk’ if
allocation was centrally determined, or through use of identical
sequentially numbered drug containers or sealed envelopes. We
scored studies as ’unclear risk’ if insufficient information was
provided.
3. Incomplete outcome data. We scored this as ’low risk’ if
there was no missing outcome data, or if the missing outcome
data was equally absent between groups or if the missing data
was unrelated to the outcome.
4. Selective outcome reporting. We considered this ’low risk’ if
the study’s protocol was available and all the primary outcomes
were reported.
5. Other sources of bias. This included any concerns we had
of biases not included in the other categories.
Two authors assessed risk of bias and resolved disagreements by
discussion. Authors were not masked to the report authors or trial
results.
Data synthesis
We combined results of studies that addressed the same compar-
ison to produce a summary risk ratio using the fixed-effect Man-
tel-Haenszel method. We assessed the amount of between-study
heterogeneity that was not explained by random error using the I²
statistic and tested for heterogeneity between trials using a stan-
dard Chi² test.
Trials of visual screening alone might be expected to produce dif-
ferent effects to trials of visual screening included in a broader as-
sessment. We decided that these two sub-groups of trials would be
analysed separately because we would find a pooled result difficult
to interpret. Furthermore, differences in the control arm of the
trials (no intervention versus standard care) may also be a source
of variation and so should also be analysed separately.
Sensitivity analysis
We anticipated that differences in trial quality may produce dif-
ferences in the effect size seen and therefore we planned sensitiv-
ity analyses to assess the effects of including or excluding trials of
different quality. We did not identify any trials at high risk of bias
in any domain so did not do this planned sensitivity analysis.
We repeated the analyses using a random-effects model for com-
parison with the results from the fixed-effect model.
We performed two post hoc sensitivity analyses:
• excluding trials that did not directly refer participants to eye
specialists; and
• reducing the effective sample size for cluster trials to take
into account the additional variation introduced by the cluster
design.
’Summary of findings’ table
We did not prepare a ’Summary of findings’ table because we only
had one major outcome in the review and three different com-
parisons. We graded the certainty of the evidence using GRADE
(Guyatt 2011). We considered risk of bias in the included trials,
inconsistency (whether the trial results were similar to each other),
imprecision (number of events/confidence intervals), indirectness
and publication bias.
R E S U L T S
Description of studies
Results of the search
The initial searches run in 1998 found 2862 citations and ab-
stracts. Of these 154 full-text articles were reviewed in detail. The
following five trials met the final inclusion criterion, that visual
outcome data were available with follow-up of at least six months:
McEwan 1990; Van Rossum 1993; Vetter 1984; Vetter 1992; and
Wagner 1994. We found no trials that were primarily of visual
screening. We excluded 16 studies: see Characteristics of excluded
studies for details.
Subsequent searches, conducted inFebruary 2006, identified 1269
titles and abstracts. After assessing the titles and abstracts we iden-
tified one study that met the inclusion criteria (Smeeth 2003).
A further update searchwas done in February 2008. The electronic
searches retrieved eight references from the Cochrane Library, 277
references from MEDLINE, 363 references from Embase and 26
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references from the UK Clinical Trials Gateway. After dedupli-
cation the search identified a total of 561 references. The Trials
Search Co-ordinator scanned the search results and removed any
references which were not relevant to the scope of the review. The
review authors identified one report as being potentially relevant
( Tay 2006); however, the review authors required information
from the study authors prior to this study being assessed for in-
clusion in the review.
Updated searches conducted in November 2017 identified 5288
new records (Figure 1). After 1257 duplicates were removed the
Cochrane Information Specialist (CIS) screened the remaining
4031 records and removed3179 referenceswhichwere not relevant
to the scope of the review. We screened the remaining 852 records
and obtained two full-text reports for further assessment. We have
included one new study in the review (Swamy 2009); and excluded
one study (Matchar 2017). In the previous version of this review
Tay 2006 was awaiting classification: we have now assessed this
study and added it to the review. We have re-assessed studies by
Moore 1997 and Eekhof 2000 and have now included them in
this update of the review. We did not identify any ongoing studies
from our searches of the clinical trials’ registries.
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Figure 1. Study flow diagram.
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Included studies
The following is a broad description of the included studies. See
’Characteristics of included studies’ table for more detailed infor-
mation on the individual trials.
Setting and participants
We identified 10 studies for inclusion in the review. Of these,
seven were individually randomised trials (McEwan 1990; Swamy
2009; Tay 2006; Van Rossum 1993; Vetter 1984; Vetter 1992;
Wagner 1994); and three were cluster randomised trials (Eekhof
2000; Moore 1997; Smeeth 2003). These trials included a total
of 10,608 participants. Smeeth 2003, was the largest study with
4340 participants.
Four of the studies were undertaken in the United Kingdom
(McEwan 1990; Smeeth 2003; Vetter 1984; Vetter 1992), all of
which recruited participants from general practice (family prac-
tice). Two studies were undertaken in Sydney, Australia, with
participants mainly recruited from outpatient aged care services
(Swamy 2009; Tay 2006). Two studies were undertaken in the
United States (Moore 1997; Wagner 1994).Two studies were un-
dertaken in the Netherlands (Eekhof 2000; Van Rossum 1993),
with Van Rossum 1993 recruiting from a defined geographic area
and Eekhof 2000 recruiting from general practice.
Interventions
In seven trials, vision screening as part of a multi-component
screening package was compared with no vision screening (stan-
dard care). These trials used questions about vision within the
screening assessment (Eekhof 2000; McEwan 1990; Moore 1997;
Van Rossum 1993; Vetter 1984; Vetter 1992; Wagner 1994). One
of these studies also measured visual acuity (Eekhof 2000). Six of
these trials had two arms, comparing multi-component screening
(including vision) with no screening (standard care). One of these
trials had three arms, comparing a multi-component screening
package including visual screening with general health promotion
without visual screening, as well as no screening (standard care)
(Wagner 1994).
In the remaining three trials, vision was directly measured. In
Smeeth 2003, all participants in the intervention arm were of-
fered a detailed health assessment including visual acuity screen-
ing. This was compared with standard care which involved a brief
health assessment including one question about vision (difficulty
reading newspaper print), but not visual acuity assessment, unless
participants met a specified range and level of problems to warrant
a more detailed assessment.
Swamy 2009 compared visual assessment alone (including visual
acuity, visual fields, intraocular pressure and contrast sensitivity)
that was not part of a multi-component screening package versus
no screening (standard care). Visual acuity was assessed using an
ETDRS chart converted to LogMAR. Tay 2006 also compared
visual screening with no visual screening, but randomised partic-
ipants into four groups: visual screening only; visual and hearing
screening; hearing screening only; and no visual or hearing screen-
ing. Visual screening involved visual acuity assessment (logMAR),
binocular near testing and visual field analysis, as well as three
questions about vision.
The type of visual intervention provided as a consequence of being
identified as having a visual problem varied between trials.Wagner
1994 provided information about resources that were available to
assist with poor vision, Van Rossum 1993 advised participants
to contact an optometrist, whereas Vetter 1984 and Vetter 1992
made referrals to an optometrist. McEwan 1990 also made refer-
rals to an optometrist as well as providing advice. Smeeth 2003
advised participants to see an optometrist or made a referral to
an ophthalmologist depending on the visual acuity. Swamy 2009
provided new glasses (as all participants receiving visual screening
were assessed by an optometrist), and made referrals to an oph-
thalmologist or occupational therapist. Moore 1997, after iden-
tifying a participant as positive following questions about vision,
went on to conduct visual acuity testing by a physician using a
Snellen chart, who arranged further investigations and subsequent
management where required. Tay 2006 referred participants to an
ophthalmologist when visual acuity was worse than 6/12, if pin-
hole improved visual acuity by 2 lines in distance vision or one
line in near vision, when visual defects were suggested or when
participants reported visual problems when visual acuity was not
measured. Participants in Eekhof 2000 had usual care for the vi-
sual disorder.
In Wagner 1994 and Moore 1997 the assessments were under-
taken at a clinic. In Smeeth 2003 33.9% of screening assessments
were undertaken in people’s own homes, the remainder being un-
dertaken at the general practice surgery. In Swamy 2009, 29% of
visual acuity assessments were conducted at home, with the re-
mainder carried out in the study clinic. Tay 2006 conducted as-
sessments in participants’ homes or at the local day hospital. In
the other trials the assessments were all undertaken in participants’
homes.
Assessments in all trialswere undertakenby specially trainednurses
or health visitors, with the exception of Swamy 2009 in which
research assistants undertook baseline testing and all visual acuity
testing was performed by a study optometrist; and Eekhof 2000
which involved general practitioners conducting the assessment.
Outcome measures
In Smeeth 2003 visual acuity was assessed using logMAR (con-
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verted to Snellen) using Glasgow Acuity Cards with a cut point
of 6/18 in either eye. Participants also completed a 25-item ver-
sion of the National Eye Institute Visual Function Questionnaire
(NEI VFQ-25) (Mangione 2001). The NEI VFQ-25 was also
used by Swamy 2009, as well as visual acuity assessed using ET-
DRS (converted to LogMAR). Tay 2006 measured visual acuity
using logMAR and EDTRS and asked three questions: whether
participants had noticed any deterioration in their vision; if they
would be able to recognise a friend across the street; and if they
had any difficulty reading newspaper print.
The remaining seven trials reported outcomes in terms of number
of participants. Six trials reported on the number of participants
who still had visual difficulties; whereas one trial reported the num-
ber of participantswhohad improvements in vision (Moore 1997).
All seven trials used questions to determine outcome, with one trial
also measuring visual acuity using a Snellen chart (Eekhof 2000).
Six trials assessed outcome by a face-to-face interview; whereas one
trial used a postal questionnaire (Wagner 1994).
There was slight variation in the wording of the questions asked
between reviews. McEwan 1990 asked about difficulty reading
newsprint; Van Rossum 1993 asked participants how they would
rate their vision; whereas Vetter 1984 and Vetter 1992 asked about
difficulty seeing in general. Moore 1997 asked about difficulty
driving, reading a newspaper or doing any other daily activities
because of visual difficulties.
Length of follow-up ranged from one to four years, except in
Smeeth 2003 where the range was three to five years.
Excluded studies
We excluded 16 trials from this review and give reasons for exclu-
sion in the Characteristics of excluded studies table.
Risk of bias in included studies
Please see Figure 2 for a summary of risk of bias.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generation
We obtained descriptions of the randomisation process for nine
trials, with randomisation performed using randomnumber tables
or randomnumber generators.We did not obtain details regarding
the generation of the allocation sequence for Eekhof 2000, which
we therefore gave a rating of ’unclear risk of bias’ for random
sequence generation.
Allocation concealment
Allocation concealment is unlikely to be an issue in cluster-ran-
domised trials so we judged these as low risk of bias (Eekhof 2000;
Moore 1997; Smeeth 2003). Most of the individually randomised
studies reported an adequate method of allocation concealment,
such as central randomisation; or indicated that the allocation was
kept separate from people recruiting participants. One study did
not provide enough information for us to make an assessment (Tay
2006).
Blinding
Masking of participants was not possible as participants would
have been aware of whether they had received a screening assess-
ment. We did not assess performance bias because we were in-
terested in the effect of assignment to the intervention, regardless
of whether the interventions were adhered to during follow-up
(Cochrane RoB 2.0 2016).
Some of the trials made attempts to mask the outcome assessors
(Swamy 2009; Van Rossum 1993), but since participants would
have been aware of whether or not they had undergone visual
screening, which arm of the trial participants were in could have
emerged during the face-to-face outcome assessments. Trials that
used postal questionnaires to participants to assess outcomeswould
have avoided this issue (Moore 1997; Wagner 1994); therefore
we assigned a ’low risk of detection bias’ to studies that made an
attempt to mask outcome assessors or used postal questionnaires.
We gave the remaining studies an ’uncertain risk of detection bias’
rating as knowledge of the participant group may have possibly
influenced the outcome, but we judged this as unlikely to be a
material bias.
Incomplete outcome data
Because of the ages of the trial participants there was a high mor-
tality rate in most of the trials.
In Smeeth 2003 around one third of participants died prior to
outcome assessment. Excluding people who had died, the overall
response rate was 62.8%. There was a slightly different response
rate between the two trial arms: 67.8% (978/1443) in the standard
care arm including one question about visual acuity, as compared
to 57.9% (829/1432) in the intervention arm who underwent
visual acuity testing. This difference was the largest of any of the
included trials and because it is not certain that this difference
would have had a material effect on the outcome, we rated this
trial as ’unclear risk of attrition bias’.
Tay 2006 had an attrition rate of 40% (85/206), but the difference
between groups was not reported and therefore we also scored this
study as ’uncertain risk of attrition bias’.
We also gave VanRossum 1993 an ’unclear risk of bias’ for attrition
since the differences between intention-to-treat and per protocol
results were not clear. It was also not clear which were presented.
Selective reporting
All nine trials reported on the pre-specified primary outcomes, and
we therefore scored them as ’low risk’ of selective reporting bias.
Other potential sources of bias
We gave Moore 1997 an ’unclear risk of bias’ since there was
the potential for recruitment bias. However, there were minimal
differences in baseline characteristics between groups, apart from
membership of a healthmaintenance organisationwhichwasmore
common in the intervention group (64% versus 33%).
We also scored Eekhof 2000 as ’unclear risk of bias’ for the po-
tential for recruitment bias. The exclusions were similar between
groups (6%versus 8%), which suggests that recruitment bias is un-
likely, but there were fewer people recruited per surgery than 160,
according to Table 1 in the trial report. This discrepancy between
the number of people selected for recruitment and actual number
of participants included in the study remains unexplained.
Effects of interventions
The results in all 10 trials were very similar and we describe them
per comparison, below.
Vision screening as part of a multi-component
screening package versus no vision screening
Within this comparison, six trials were meta-analysed. There was
no evidence of heterogeneity of effect between six trials (I² was 0%,
Chi² = 1.27, df = 5, P = 0.94) assessing vision screening (questions)
as part of a multi-component screening package versus no vision
screening. The pooled risk ratio for people in the intervention and
control groups having self-reported visual problemswhenoutcome
assessmentswere performedwas 1.05 (95%CI0.97 to 1.14), high-
11Community screening for visual impairment in older people (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
certainty evidence (Analysis 1.1). Similar results were seen with a
random-effects model (RR 1.06, 95% CI 0.97 to 1.15).
We performed two post hoc sensitivity analyses. Firstly, excluding
trials that did not directly refer participants to eye specialists (i.e.
Wagner 1994 and Van Rossum 1993) did not result in any signifi-
cant changes to the meta-analysed results, with a pooled risk ratio
of 1.06 (95% CI 0.96 to 1.17), with no evidence of heterogeneity
(I² was 0%, Chi² = 0.81, df = 3, P = 0.85). Secondly, reducing
the effective sample size of the one cluster trial - Eekhof 2000 -
by dividing by an estimated design effect of 2 did not make any
important difference to the estimate and precision of the overall
effect (RR 1.04, 95% CI 0.95 to 1.15).
The remaining trial within this comparison was included under
a different outcome as “improvement in vision” was determined
not to be the direct inverse of “not seeing well”. In Moore 1997,
after 6 months 20/99 (20%) individuals who had visual screening
reported an improvement in vision, as compared to 31/131 (24%)
who had not undergone visual screening, with a risk ratio of 0.85
(95%CI 0.52 to 1.40), moderate-certainty evidence (downgraded
one level for imprecision).
Vision screening only versus no vision screening
This comparison included two studies, Swamy 2009 and Tay
2006. In Swamy 2009, after one year’s follow-up, visual acuity
in the screened and non-screened groups was similar. The mean
distance logMAR visual acuity in the vision screening group was
0.27, as compared to 0.25 in the standard care group (i.e. no
screening), with a mean difference between groups of 0.02 (95%
CI −0.02 to 0.06), high-certainty evidence.
Themean near logMAR visual acuity in the visual screening group
was −0.01 as compared to−0.03 in the standard care group, with
a difference of 0.02 (95% CI −0.03 to 0.07), high-certainty evi-
dence. There was no evidence of any important difference in qual-
ity of life. The mean VFQ in the visual screening group was 84.3
and 86.4 in the standard care group, with an adjusted mean dif-
ference of −0.06 (95% CI −2.3 to 1.1), high-certainty evidence;
adjustments were made for baseline VFQ-25 scores.
We could not calculate a mean difference from Tay 2006, as the
number of participants who had been followed up per arm could
not be determined.However, the authors state that themean visual
acuity in participants who had visual acuity assessed (intervention)
at baseline (39 letters) was non-significantly better than those who
did not have their visual acuity assessed (35 letters, P = 0.25).
Vision screening (visual acuity test) as part of a multi-
component screening package versus vision screening
(question about vision) as part of a multi-component
screening package (standard care)
In Smeeth 2003, three to five years after screening, the risk ratio
for visual acuity less than 6/18 in either eye, comparing visual
acuity screening to usual care, was 1.07 (95% CI 0.84 to 1.36, P =
0.58), moderate-certainty evidence (downgraded for imprecision)
after adjustment for cluster design. There was little evidence of
any difference in quality of life. The mean composite score of the
NEI VFQ-25 was 85.6 in the standard care group and 86.0 in
the intervention group, difference 0.4 (95% CI −1.7 to 2.5, P =
0.69), high-certainty evidence.
D I S C U S S I O N
Summary of main results
This systematic review included three comparisons, all of which
provided predominantly high-certainty evidence of a lack of effect
of vision screening in older people.
The first comparison included seven trials comparing visual screen-
ing involving some questions about vision as part of a multi-com-
ponent screening versus no screening (standard care). Six of these
seven trials were included in a meta-analysis, with pooled propor-
tions of participants indicating no difference between the inter-
vention and control groups who reported on-going vision prob-
lems. The remaining trial, Moore 1997, also showed no difference
in the number of participants reporting an improvement in vision
between groups.
The second comparison included two studies which compared
vision screening with no screening (standard care). Neither study
demonstrated a difference between groups in terms of visual acuity
or difference in quality of life.
The final comparison included Smeeth 2003, which showed no
difference in visual outcome between a detailed health assessment
including measurement of visual acuity and a brief health assess-
ment including one question about vision (standard care).
Visual impairment is common among older people and is fre-
quently unreported. It has several adverse associations including
falls, reduced quality of life and reduced functional ability (Smeeth
1998a). Results from community surveys in the ’over 75 years’ age
group suggest that over half the visual impairment in this age group
could potentially be reduced with treatment, notably by cataract
surgery or refractive correction (Klein 1991; Wormald 1992).
Possible explanations for lack of effectiveness
It has been suggested that vision screening alone rather than as
part of a multi-component screening assessment would be more
effective (SLSSG 1977; Stone 1978). However, in clinical practice
screening for visual impairment is highly likely to be one part
of a broader screening package and, therefore, an assessment of
effectiveness within a broader package is the most pragmatically
useful measure. Moreover the two latest trials, Swamy 2009 and
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Tay 2006, which used screening for visual impairment in isolation
as their intervention, did not demonstrate an improvement in
visual acuity or an improved score on the National Eye Institute
Visual Function Questionnaire.
Nonetheless, there are a number of factors that remain which may
have contributed to the lack of effectiveness of visual screening.
Firstly, a screening procedure alone would not be expected to lead
to improvements in vision. Such improvements would be depen-
dent on the subsequent interventions to improve vision. There
were considerable differences in the subsequent follow-up of pa-
tients found to have visual problems between studies, but the re-
sults of the post hoc sensitivity analysis excluding those studies
that did not directly refer to eye specialist services, did not re-
sult in differing results of the meta-analysis. Some of the trials
provided information regarding the uptake of interventions. In
Smeeth 2003, for people with visual impairment not thought to
be due to refractive error, 35% had seen an ophthalmologist in
the past 12 months and a further 14% were registered blind or
partially sighted. Both these groups were not eligible for referral.
Only around half of those people recommended for referral to
an ophthalmologist were actually referred; although when referral
did occur, attendance at eye clinics was high. People with worse
vision were more likely to be referred and people with evidence
of cognitive impairment at the time of screening were less likely
to be referred. However, explanations for the low adherence by
general practitioners to recommendations for referral are lacking.
Around half of those who attended an ophthalmologist following
screening had cataract surgery and their vision improved. Among
the remaining people who attended an ophthalmologist following
screening, there was no improvement in visual acuity. It is possible
that some of these people received interventions for low vision
that were of benefit in terms of function and quality of life, but
that would not be expected to improve visual acuity. However, the
result for visual function did not differ in the two trial arms. The
study authors concluded that while overall as a result of the vi-
sual screening some people obtained beneficial interventions, the
numbers of people benefiting was small in the context of a pop-
ulation-based screening programme and were not sufficient to af-
fect the prevalence of visual impairment among all participants.
In Swamy 2009, 135 out of 146 participants (92%) took up treat-
ment or referral. The majority of participants received glasses (92
people out of 135, 68%), 77% of which were delivered within
60 days. However, less than half the participants who were re-
ferred to an ophthalmologist or optometrist actually received a
treatment. In Moore 1997, 19/20 participants in the intervention
group took up the intervention that was recommended following
visual screening, as compared to 17/19 participants in the control
group. In Tay 2006, 37 out of 42 participants (88%) complied
with the recommendation to see an eye-care professional. None of
the remaining five trials provided details as to uptake of interven-
tions. Although sparse details are provided on who conducted the
screening, it is not clear how effective the communication was be-
tween the screener and the participant. It would seem reasonable
that the effectiveness of the communication provided may have
had an impact on the uptake of interventions: if communication
between the screener and participant was poor, they may have felt
less inclined to follow the recommendation.
Secondly, individuals who reported visual problems when
prompted to do so in a screening programme may not have per-
ceived their previously unreported visual impairment as a ’need’
for intervention. Gradual adjustment to, and assimilation of, re-
duced visual function may occur with ageing among some peo-
ple. Therefore, in spite of reporting problems with vision when
asked directly, they may not have acted on advice to seek further
care. There is very little information on whether older people ac-
cept interventions for visual problems discovered by screening. In
a randomised trial of multi-component screening in the United
States 15 out of 18 older people complied with advice to attend
for an eye examination (Fabacher 1994). In a United Kingdom
general practice-based survey one third of those referred to the eye
services with a visual problem did not attend (Wormald 1992). In
addition to participants not concurring with the need for interven-
tion, there may have been barriers to obtaining help with the eye
problems identified. Possible barriers include: costs of further eye
tests, glasses and other treatments; and an inability of ophthalmic
services to meet demand, for example for cataract extraction. A
further reason may be simple acceptance of gradual decline in vi-
sual function with age and limited understanding of the potential
benefits from intervention.
Thirdly, trials using questions about vision both for the initial
screening assessment and for the outcome assessment may have
affected the results. Questions about vision have a low sensitivity
and, to a lesser extent, a low specificity for detecting visual impair-
ment when compared to formal acuity testing (Smeeth 1998a).
However, in the four trials that measured visual acuity both at
the screening assessment and at the outcome assessment (Eekhof
2000; Smeeth 2003; Swamy 2009; Tay 2006), the lack of effect of
screening on visual outcomes was very similar to the results seen
in the remaining trials.
Overall completeness and applicability of
evidence
All studies within this review included participants who were in-
dependent and living in the community and several studies specif-
ically excluded participants who lived in residential or nursing care
(Smeeth 2003; Van Rossum 1993, Vetter 1984; Wagner 1994).
Therefore participants in these studies were likely to be able to
independently seek ophthalmic intervention should they see a
need to do so. This assumption is corroborated by the findings of
Swamy 2009 andTay 2006: 72%of the control armwithin Swamy
2009 consulted with an eye-care professional in the preceding 12
months and 74% participants within Tay 2006 consulted with an
eye care specialist within the study period regardless of baseline
13Community screening for visual impairment in older people (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
recommendation. As such, the findings of this review may not be
applicable to more dependent older people living in residential or
nursing care. Of note:a previously conducted community survey
suggested that over half the visual impairment in this age group
could potentially be reduced with treatment included housebound
older people (Wormald 1992) - a different population from the
trials. Future trials should focus on recruiting participants who are
more dependent and less able to seek ophthalmic intervention, as
a greater benefit may be derived in this population.
Certainty of the evidence
The certainty of the evidence within this review is graded as ’high’,
since each of the three comparisons contained high-certainty evi-
dence.
The statistical estimates of effect were reasonably precise and trials
reported consistent results. Additionally, although there was vari-
ation in the design of the trials necessitating three comparisons
within this review, all trials addressed the question and outcomes
were relevant.
Potential biases in the review process
We followed standard Cochrane methods in the process of up-
dating this review. The protocol was also updated in response to
Cochrane methods guidance, rather than through knowledge of
the data.
Agreements and disagreements with other
studies or reviews
A similar systematic review - Chou 2009 - which has been recently
updated by the U.S. Preventive Services Task Force Recommen-
dation (Chou 2016), drew conclusions in line with this review.
Specifically, they found “no significant difference between vision
screening in older adults in primary care settings, versus no screen-
ing for improving visual acuity or other clinical outcomes.” Three
randomised controlled trials were included in Chou 2016, all of
which are also included in this review (Eekhof 2000;Moore 1997;
Smeeth 2003).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from randomised controlled trials undertaken to
date does not support vision screening intervention for older peo-
ple in a community setting. This is true for screening programmes
involving questions about visual problems, or directmeasurements
of visual acuity. Similarly, there was no benefit derived from vision
screening in isolation or as part of a multi-component screening
package.
Implications for research
Given the importance of visual impairment among older people,
further research into strategies to improve vision of older people
is needed. The effectiveness of an optimised primary care-based
screening intervention that overcomes possible factors contribut-
ing to the observed lack of benefit in trials to date warrants assess-
ment.
There are a number of unresolved issues around optimal tools to
be used for screening for visual impairment, particularly in the
context of multidimensional screening in primary care. Whether
visual acuity is a good screening tool to identify people who are
likely to benefit from interventions to improve their vision needs
to be assessed. The value of screening for other measures such as
visual fields or contrast sensitivity warrants further work. While
single questions about self-reported visual difficulties are poor pre-
dictors of low visual acuity, the development of brief screening in-
struments that assess visual function could be of great value (Iliffe
2005).
With regards to multidimensional assessment for older people, in
the one trial with data on this issue the low level of ophthalmo-
logical referrals for those people deemed eligible for referral fol-
lowing screening was notable. There is scope for more research
on the determinants of clinician adherence to recommendations
for referrals arising from multidimensional assessments. Specific
issues of interest are assessing the appropriateness of the referral
decisions made and the role of the patient in the decision whether
to refer or not.
The effectiveness of an increased role for optometry services in
the detection and management of visual problems among older
people on a population basis warrants evaluation.
Detailed prospective research on the detection, referral, diagnosis
and management of visual problems in older people could help
shed further light on the reasons for the ineffectiveness of screen-
ing. As well as looking at health service issues, research from the
perspective of the older people themselves is also needed. Areas
which particularly need to be addressed include: older people’s
perceptions of their visual problems and of the need for interven-
tions; and perceived barriers to interventions to help their vision.
There is also a need to evaluate the impact of vision screening in
more dependent populations of older people. The findings of two
studies in this review highlighted that many of the control arm
participants sought assessment from an eye care speciality inde-
pendently (Swamy 2009; Tay 2006). Participants who live in res-
idential or nursing homes are arguably less able to seek help when
needed and therefore there may be greater benefit to providing
visual screening in this subpopulation.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Eekhof 2000
Methods Cluster randomised trial of 12 general practitioners
Participants Geographic region: Netherlands
First 160 patients in alphabetical order from each surgery
Age: over 75
Exclusion criteria: too ill, suffering from dementia, not able to participate for other
reasons n = 1028
Interventions Each practice was randomised to either:
(1) Intervention group: multi-component screening package including 4 disorders (vi-
sion, hearing, urinary incontinence and mobility) using self-reporting OECD question-
naire as well as diagnostic tests during the first year.When the GP and the patient agreed
on the intervention, usual care was provided, n = 483
(2) Control group: no screening (standard care) during the first year, then underwent
same multi-component screening package as the intervention group at year 2, n = 545
Outcomes Presence of a visual disorder at 12 months in intervention group versus control group
A visual disorder was defined as “having difficulty recognising a face at 4 m and/ or
reading normal letters in a newspaper and/ or impaired vision in both eyes (Snellen chart
<0.3 or not being able to read normal newspaper letters at 25cm distance).”
Notes Funding source: Robert Wood Johnson Clinician Scholars Programme and the National
Institute on Aging Geriatric Academic Programme
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation not reported.
“Randomised in 6 strata pairs of GPs,
matched by town/ countryside group/ solo
practice, age, sex and number of years prac-
ticing as a GP”
Allocation concealment (selection bias) Low risk Cluster randomised trial
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
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Eekhof 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Some imbalance in follow-up but groups
reasonably balanced in terms of reason for
loss to follow-up and thought to be too
minimal to significantly affect results
Intervention: 483/732 (66%)
Control: 545/738 (74%)
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Unclear risk Uncertain risk of recruitment bias - the
exclusions were similar between (6% ver-
sus 8%) groups, which suggests that re-
cruitment bias is unlikely to be a problem,
but there were fewer people recruited per
surgery than 160, according to Table 1,
which remains unexplained
McEwan 1990
Methods Randomised: random number generator, centrally
Stratified by age: 75 to 84, 85+
Masking: outcome assessors not masked
Participants Geographic region: United Kingdom
All people registered with a general practice
Age: over 75
Exclusion criteria: too ill for assessment or in hospital (11)
Prior to randomisation all participants interviewed regarding mental and physical health
and functioning, including questions about vision
N = 296
Interventions (1)multi-component home nurse assessment (including social functioning, currentmed-
ical problems and additional question about vision). Those reporting visual problems
given advice and referred to an optometrist (n = 151)
(2) Usual care (n = 145)
Follow-up period: 20 months
Outcomes Proportion who ’always’ or ’quite often’ had difficulty reading ordinary newsprint (with
glasses if worn)
Attrition: outcome data available on 78% of participants in intervention group (16
deaths and 17 lost to follow up) and 77% in control group (23 deaths and 11 lost to
follow up)
Notes Funding source: Newcastle Health Authority
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
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McEwan 1990 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly allocated to groups, by random
number generator.
Allocation concealment (selection bias) Low risk Randomisation conducted centrally.
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rate fully explained and equal be-
tween groups.
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None apparent.
Moore 1997
Methods Cluster randomised controlled trial of 26 internists and family physicians
Participants Geographic region: Greater Los Angeles
8 to 12 patients from each of the internist’s or family physician’s practice
Age: Over 70
Exclusion criteria: not acutely/ terminally ill, able to answer questions
161 patients within 26 practices
Interventions Each practice was randomised to either:
(1) Visual screening as part of multi-component package. Baseline and follow-up ques-
tionnaires (MOS SF-36), with screening assessment. This involved an eight item screen-
ing questionnaire/assessment including a visual screening question; ’Do you have any
difficulty driving or watching television or reading or doing any of the activities because
of your eyesight?’. If a positive screen was identified, then Snellen visual acuity assessment
performed by physician and unknown interventions provided. (n = 112)
(2) N visual screening - standard care. Baseline and follow-up questionnaires (MOS SF-
6) provided as in the intervention group (n = 149)
Outcomes Frequency of self-reported improvement in vision via questionnaire
Attrition rate: 31 total across both arms, with 17 = refusal, 4 = moving away, 8 = loss to
follow-up, 2 = death
Follow-up: 6 months
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Moore 1997 (Continued)
Notes Cluster randomised
Funding source: Robert Wood Johnson Clinician Scholars Programme and the National
Institute on Aging Geriatric Academic Program
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table used.
Allocation concealment (selection bias) Low risk Allocation concealment is unlikely to be an
issue in cluster-randomised trials
Blinding of outcome assessment (detection
bias)
Not seeing well
Low risk Questionnaire used to assess outcome.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Equal attrition rate (12%) between groups.
Explained, but reasons not provided per
group.Good follow-up rate considering the
age group
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Unclear risk Practice was aware of allocation at the time
of recruiting participants so there was po-
tential for recruitment bias. On the whole
the groups were well balanced apart from
membership of a health maintenance or-
ganisation which was more common in the
intervention group (64% versus 33%)
Smeeth 2003
Methods Centralised cluster computer generated randomisation of general practices
Participants Geographic region: United Kingdom
A random sample of 220 people registered with each general practice and eligible for
trial entry
Age: Over 75
Exclusion criteria: terminal illness or resident in a long-stay hospital or nursing home
20 practices randomised, with a total of 4340 participants
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Smeeth 2003 (Continued)
Interventions Participants were randomised to one of two screening strategies
(1) Universal screening group: all trial participants were invited to complete a brief
assessment followed by a detailed health assessment by a trained nurse that included
measurement of visual acuity on the logMAR scale using a Glasgow acuity chart. People
with visual acuity less than 6/18 in either eye hadmeasurements repeated using a pinhole
occluder. Participants with a pinhole vision of less than 6/18 in either eye were referred
to an ophthalmologist unless they were registered blind or had seen an ophthalmologist
in the previous year. Participants presenting with vision of less than 6/18 in either eye
that improved with pinhole to better than 6/18 were advised to see an optician
N = 2140 randomised. 1565 had an assessment, response rate 73.1%
(2) Targeted screening group: participants were invited to complete a brief screening
assessment that included a question about difficulty seeing. Only people found to have
a pre-specified range and level of problems during the brief assessment were invited to
have a detailed assessment including visual acuity
N = 2200 randomised. 1684 had an assessment, response rate 76.5%
120 people out of the 1684 who had a brief assessment went on to have visual acuity
measured
Follow-up period: 3 to 5 years
Outcomes Visual acuity less than 6/18 in either eye and mean composite score of the NEI VFQ-
25 comparing universal with targeted screening
A total of 1807 outcome assessments were completed. Around one third of participants
died prior to outcome assessment. Excluding people who had died the response rate
was 67.8% (978/1443) in the targeted group and 57.9% (829/1432) in the universal
screening group
Notes Cluster randomised
Funding source: MRC and Department of Health
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated randomisation list
used.
Allocation concealment (selection bias) Low risk Randomisation performed centrally.
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition rate fully explained, but slightly
different rates between groups (67.8% ver-
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Smeeth 2003 (Continued)
sus 57.9%) which could have affected out-
come
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None apparent.
Swamy 2009
Methods Randomised using random number tables, to blocks of size 4.
Stratified by sex, falls history and recruitment source.
Investigator allocating participants by allocation sequence had no contact with study
subjects
Participants Geographic region: community in Sydney, Australia
Contact details obtained from range of care service providers and local advertisements
placed
Age: 70 years or older
Exclusion criteria: cataract surgery or new spectacle prescription in last 3 months
N = 616
Interventions (1) Vision tests and eye examinations by an optometrist, with appropriate treatment
(new spectacles, referral to ophthalmologist, referral to occupational therapist). n = 309
(2) Standard care, no visual screening, n = 307
Follow-up = 12 months
Outcomes Baseline assessment: socio-economic details, medical history, history of vision and eye
problems, falls history, use of psychotropic medications, activities of daily living (ADLs),
25-itemNational Eye Institute Visual Function Questionnaire (VFQ-25), and theMini-
Mental State Examination (MMSe), visual acuity with near and distance logMAR
Attrition rate = 35 (intervention group) versus 49 (control group), reasons provided
Follow-up: follow-up questionnaire including VFQ-25, binocular visual acuity, whether
or not had seen an eye-care practitioner in the past year (if so, when)
Data adjusted for baseline VFQ-25 scores.
Notes Funding source: National Health and Medical Research Council of Australia
Declaration of interest: none
Date study conducted: Not recorded
Trial registration number: Not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number tables used.
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Swamy 2009 (Continued)
Allocation concealment (selection bias) Low risk Randomnumbers used by investigator who
had no contact with participants
Blinding of outcome assessment (detection
bias)
Not seeing well
Low risk Attempts made to mask assessor - research
assistants were “unaware of group alloca-
tion”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rate fully explained.
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None.
Tay 2006
Methods Randomisation performed using computer generated random numbers with block de-
sign. Participants randomised into 4 groups; vision and hearing screening, vision screen-
ing only, hearing screening only, no screening (standard care)
No masking was performed.
Participants Geographic region: Sydney, Australia
Patients attending aged care services at Westmead Hospital, Sydney
Age: 65 years and over
Exclusion criteria: profound dementia, non-English speaking
N = 206 randomised
Interventions (1) Visual acuity screening (including groups with visual screening only and visual and
hearing screening combined). VA testing (logMAR), binocular near testing, visual field
testing (confrontation), n = 96
Under-corrected refractive error (pinhole VA improved at least 10 letters in those present-
ing with VA < 6/6), bilateral visual impairment (better eye VA < 6/12) or self-reported
visual problems were recommended to have further assessment by eye-care professionals
(2) No visual acuity screening (including groups with hearing screening only and no
screening), n = 92
Routine aged care assessment and interview using a standardised questionnaire
All participants hadMMSE, sociodemographic information, self-rated health, past med-
ical histories, use of community support services and details of informal help
Outcomes Improvement in visual acuity in one or both eyes at follow-up (1 year)
Number of individuals that were followed up (n = 121) not provided per group, but
authors report “the mean VA in participants who had VA assessed (intervention) at
baseline (39 letters) was non-significantly better than those who did not have their VA
assessed (35 letters, p = 0.25).”
Attrition: 85/206 = 40% dropped out after randomisation.
Rates between groups not provided.
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Tay 2006 (Continued)
Notes Funding sources: University of Sydney SESQUI Ophthalmic Research Institute of Aus-
tralia (ORIA grant 2004), University of Sydney Postgraduate Award, Westmead Millen-
nium Foundation Research Scholarship Stipend Enhancement Grant
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Contact from author: randomisation per-
formed using computer generated random
numbers with block design
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 121/206 = 59% randomised participants
seen at follow-up. Follow-up rate by inter-
vention group not reported
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None.
Van Rossum 1993
Methods Randomised: random numbers generator, centrally
Stratified prior to randomisation by sex, self-rated health, composition of household and
neighbourhood
Masking: outcome assessors masked
Participants Geographic region: the Netherlands
All people living at home in a geographically defined area were sent a postal invitation
Age: 75 to 84
Exclusion criteria: people already receiving home nursing care or their partners (126);
people living in a monastery (20)
N = 580
Interventions (1) Four visits per year for 3 years by trained nurses. One question about vision: ’How
do you assess your vision at present?’ Possible answers: excellent, good, fair, not so good
or bad. Those answering ‘fair’, ’not so good’ or ‘bad’ to the screening question advised
to contact an optometrist (n = 292)
25Community screening for visual impairment in older people (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Van Rossum 1993 (Continued)
(2) Usual care, no screening (n = 288)
Follow-up period: 3 years
Outcomes Proportion answering ‘fair’, ‘not so good’ or ‘bad’ to the screening question at the end
of the study
Attrition: outcome data available on 79% of participants in intervention group (42
deaths and 19 lost to follow-up) and 77% in control group (50 deaths and 17 lost to
follow-up)
Notes Funding source:NetherlandsMinistry ofWelfare,Health andCultural Affairs, the Foun-
dation for Research and Development of Social Care (STOOM) and Het Praeventie-
fonds
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random numbers.
Allocation concealment (selection bias) Low risk Randomisation conducted centrally.
Blinding of outcome assessment (detection
bias)
Not seeing well
Low risk Attempts were made to mask assessor: “in-
terviews were conducted by trained inter-
viewers, who were unaware of whether a
participant had been regularly visited by a
nurse or not”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Analysed data per protocol and ITT but
no comment on differences between these
results and unclear which are reported
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None.
Vetter 1984
Methods Randomised by household: random number tables, centrally. Household randomisation
undertaken because it was felt it would be difficult for the health visitor to intervene on
behalf of one member of a household and not for another
Masking: outcome assessors masked
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Vetter 1984 (Continued)
Participants Geographic region: United Kingdom
People living at home registered with one of two general practices
Age: over 70
Exclusion criteria: people in permanent residential care
N = 1148
Interventions (1) Annual assessment at home by a health visitor. Two questions about glasses and
difficulty seeing. Those reporting difficulties seeing were referred to an optometrist or
to their general practitioner and were offered advice from the health visitor (n = 577)
(2) Usual care, no screening (n = 571)
Follow-up period: 2 years
Outcomes Proportion with a positive response to the question at interview: ‘Do you have any
difficulty seeing (even when wearing your glasses)’
Attrition: outcome data available on 84% of participants in intervention group (80
deaths and 9 lost to follow up) and 79% in control group (105 deaths and 10 lost to
follow up)
Notes Funding source: Welsh Office and Department of Health and Social Security
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly allocated to groups, using ran-
dom number tables.
Allocation concealment (selection bias) Low risk Randomisation conducted centrally.
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rate fully explained.
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None.
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Vetter 1992
Methods Randomised: random number tables, centrally. Household randomisation undertaken
because part of intervention included improvements in the home environment
Masking: outcome assessors masked
Participants Geographic region: United Kingdom
People registered with one general practice
Age: 75 and over
Exclusion criteria: people excluded by general practitioners because it was felt they were
likely to refuse trial entry (9)
N = 674
Interventions (1) Annual assessment at home by a health visitor, specifically aimed at reducing falls and
fractures. Two questions about glasses and difficulty seeing, and third question about
recent eye tests. Those reporting difficulties seeing were referred to an optometrist or to
their general practitioner, and were offered advice from the health visitor (n = 350)
(2) Usual care, no screening (n = 324)
Follow-up period: 4 years
Outcomes Proportion with a positive response to the interview question ‘Do you have any difficulty
seeing (even when wearing your glasses)’
Attrition: outcome data available on 69% of participants in intervention group (88
deaths and 22 lost to follow-up) and 65% in control group (106 deaths and eight lost
to follow-up)
Notes Funding source: the Grand Charity and the Welsh Office
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table used.
Allocation concealment (selection bias) Low risk Use of study numbers without direct con-
tact from participants
Blinding of outcome assessment (detection
bias)
Not seeing well
Unclear risk Masking of assessors not performed -
knowledge of intervention could have in-
fluenced outcome, but judged unlikely to
be a material bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rate fully explained.
Selective reporting (reporting bias) Low risk Primary outcomes reported.
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Vetter 1992 (Continued)
Other bias Low risk None.
Wagner 1994
Methods Randomised: random number table, independent of trialists or participants
Masking: outcomes assessed by postal questionnaire, no masking
Participants Geographic region: United States
Random sample of health maintenance organisation enrollees
Age: over 65
Exclusion criteria: people in residential care, people too ill to undertake the assessment
N = 1559
Interventions (1) Invited for a multi-component nurse assessment (including vision) aimed at reducing
disability and falls. Those reporting problems received information about resources in
the community designed to assist those with poor vision (n = 635)
(2) Invited to a general health promotion visit with no visual assessment (n = 317)
(3) Usual care, no screening (n = 607)
Follow-up period: 2 years
Outcomes Proportions reporting visual problems on a mailed questionnaire
Attrition: 5% of total (89), 53 deaths, 18 refusals, 15 too ill, 2 institutionalised, 1 could
not be contacted.
Author states attrition evenly distributed across groups
For this review, group 1 (who received a visual screen) has been analysed against groups
2 and 3 together (who received no visual screen)
Notes Funding source: Centres for Disease Control
Declaration of interest: not recorded
Date study conducted: not recorded
Trial registration number: not recorded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomly allocated to groups, using ran-
dom number table.
Allocation concealment (selection bias) Low risk Allocation independent of trialists.
Blinding of outcome assessment (detection
bias)
Not seeing well
Low risk Questionnaire used to assess outcome.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rate very low and fully explained.
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Wagner 1994 (Continued)
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk None.
General practice is equivalent to family practice
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Carpenter 1990 Visual outcomes not measured
Clarke 1992 Intervention did not include assessment of vision
Epstein 1990 Visual outcomes not measured
Fabacher 1994 Visual outcomes not measured
Hall 1992 Visual outcomes not measured
Hanger 1990 No control group
Hendriksen 1984 Visual outcomes not measured
Matchar 2017 Not a general population group - participants were recently discharged from emergency department and study
was aimed at falls prevention rather than vision improvement
Pathy 1992 Visual outcomes not measured
Rubenstein 1986 No control group
Sorensen 1988 Visual outcomes not measured
Stone 1978 Participants aged 64 years and under only
Stuck 1995 Visual outcomes not measured
Tinetti 1994 Visual outcomes not measured
Tulloch 1979 Visual outcomes not measured
Williams 1987 Visual outcomes not measured.
Yeo 1987 Visual outcomes not measured
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D A T A A N D A N A L Y S E S
Comparison 1. Vision screening as part of multi-component screening package versus no vision screening (standard
care)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Not seeing well (as defined by
each trial)
6 4522 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.97, 1.14]
Analysis 1.1. Comparison 1 Vision screening as part of multi-component screening package versus no vision
screening (standard care), Outcome 1 Not seeing well (as defined by each trial).
Review: Community screening for visual impairment in older people
Comparison: 1 Vision screening as part of multi-component screening package versus no vision screening (standard care)
Outcome: 1 Not seeing well (as defined by each trial)
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Eekhof 2000 (1) 248/483 257/545 36.6 % 1.09 [ 0.96, 1.23 ]
McEwan 1990 (2) 21/118 19/111 3.0 % 1.04 [ 0.59, 1.83 ]
Van Rossum 1993 (3) 99/231 87/221 13.5 % 1.09 [ 0.87, 1.36 ]
Vetter 1984 (4) 161/486 141/453 22.1 % 1.06 [ 0.88, 1.28 ]
Vetter 1992 (5) 75/240 68/207 11.1 % 0.95 [ 0.73, 1.25 ]
Wagner 1994 (6) 74/581 111/846 13.7 % 0.97 [ 0.74, 1.28 ]
Total (95% CI) 2139 2383 100.0 % 1.05 [ 0.97, 1.14 ]
Total events: 678 (Intervention), 683 (Control)
Heterogeneity: Chi2 = 1.27, df = 5 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.25)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours intervention Favours control
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(1) The outcome measure for this study was determined through the use of questions about vision and visual acuity assessment using a Snellen Chart.
(2) The outcome measure for this study involved the use of questions only.
(3) The outcome measure for this study involved the use of questions only.
(4) The outcome measure for this study involved the use of questions only.
(5) The outcome measure for this study involved the use of questions only.
(6) The outcome measure for this study involved the use of questions only.
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Vision Screening] explode all trees
#2 MeSH descriptor: [Mass Screening] explode all trees
#3 screen*
#4 MeSH descriptor: [Preventive Health Services] explode all trees
#5 MeSH descriptor: [Health Promotion] explode all trees
#6 MeSH descriptor: [Activities of Daily Living] explode all trees
#7 MeSH descriptor: [Diagnostic Services] explode all trees
#8 MeSH descriptor: [Multiphasic Screening] explode all trees
#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8
#10 MeSH descriptor: [Aged] explode all trees
#11 MeSH descriptor: [Aged, 80 and over] explode all trees
#12 (geriatric* or elderly or senior)
#13 #10 or #11 or #12
#14 #9 and #13
#15 MeSH descriptor: [Geriatric Assessment] explode all trees
#16 MeSH descriptor: [Health Services for the Aged] explode all trees
#17 #15 or #16
#18 #14 or #17
#19 MeSH descriptor: [Eye Diseases] explode all trees
#20 MeSH descriptor: [Visual Acuity] explode all trees
#21 (eye* or vision or visual or macula* degeneration or cataract* or presbyopia)
#22 #19 or #20 or #21
#23 #18 and #22
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Appendix 2. MEDLINE Ovid search strategy
1. randomized controlled trial.pt.
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. exp animals/
10. exp humans/
11. 9 not (9 and 10)
12. 8 not 11
13. exp vision screening/
14. Mass Screening/
15. multiphasic screening/
16. screen$.tw.
17. Preventive Health Services/
18. Health Promotion/
19. Activities of Daily Living/
20. Diagnostic Services/
21. or/13-20
22. exp aged/
23. “Aged, 80 and over”/
24. (geriatric$ or elderly or senior$).tw.
25. or/22-24
26. 21 and 25
27. Geriatric Assessment/
28. Health Services for the Aged/
29. or/27-28
30. 26 or 29
31. exp eye diseases/
32. exp visual acuity/
33. (eye$ or vision or visual or macular degeneration or cataract$ or presbyopia).tw.
34. or/31-33
35. 30 and 34
36. 12 and 35
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville 2006.
Appendix 3. Embase Ovid search strategy
1. exp randomized controlled trial/
2. exp randomization/
3. exp double blind procedure/
4. exp single blind procedure/
5. random$.tw.
6. or/1-5
7. (animal or animal experiment).sh.
8. human.sh.
9. 7 and 8
10. 7 not 9
11. 6 not 10
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12. exp clinical trial/
13. (clin$ adj3 trial$).tw.
14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15. exp placebo/
16. placebo$.tw.
17. random$.tw.
18. exp experimental design/
19. exp crossover procedure/
20. exp control group/
21. exp latin square design/
22. or/12-21
23. 22 not 10
24. 23 not 11
25. exp comparative study/
26. exp evaluation/
27. exp prospective study/
28. (control$ or prospectiv$ or volunteer$).tw.
29. or/25-28
30. 29 not 10
31. 30 not (11 or 23)
32. 11 or 24 or 31
33. exp vision test/
34. mass screening/
35. screen$.tw.
36. preventive health service/
37. health promotion/
38. daily life activity/
39. or/33-38
40. exp aged/
41. exp senescence/
42. (geriatric$ or elderly or senior$).tw.
43. or/40-42
44. 39 and 43
45. geriatric assessment/
46. elderly care/
47. or/45-46
48. 44 or 47
49. exp eye disease/
50. exp visual acuity/
51. (eye$ or vision or visual or macula$ degeneration or cataract$ or presbyopia).tw.
52. or/49-51
53. 48 and 52
54. 32 and 53
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Appendix 4. ISRCTN search strategy
screen AND community AND elderly
Appendix 5. ClinicalTrials.gov search strategy
screen AND community AND elderly AND (vision OR visual OR sight)
Appendix 6. WHO ICTRP search strategy
screen AND community AND elderly AND vision
WH A T ’ S N E W
Last assessed as up-to-date: 23 November 2017.
Date Event Description
6 January 2017 New citation required but conclusions have not changed Issue 2, 2018: Four new trials included (Eekhof 2000;
Moore 1997; Swamy 2009; Tay 2006)
6 January 2017 New search has been performed Issue 2, 2018: Electronic searches updated
H I S T O R Y
Protocol first published: Issue 1, 1998
Review first published: Issue 3, 1998
Date Event Description
9 May 2008 New search has been performed Electronic searches have been updated.
23 April 2008 Amended Converted to new review format.
2 March 2006 New citation required and conclusions have changed Substantive amendment
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C O N T R I B U T I O N S O F A U T H O R S
Conceiving the idea for the review: SI
Developing the review: LS
Undertaking manual searches for trials: LS
Assessing quality of trials: ELC, LS, JE
Extracting data: ELC, LS, JE
Analysing data: ELC, LS, JE
Writing the review: ELC, LS, JE
Advising on the review: LS, JE
Updating the review: ELC, LS, JE
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• London Academic Training Scheme, UK.
External sources
• Medical Research Council, UK.
• National Institute for Health Research (NIHR), UK.
• Richard Wormald, Co-ordinating Editor for Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV
research sessions from the Department of Health through the award made by the NIHR to Moorfields Eye Hospital NHS
Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology.
• This review update was supported by the NIHR, via Cochrane Infrastructure funding to the CEV UK editorial base.
The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews
Programme, NIHR, NHS or the Department of Health.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made some changes because of updated Cochrane guidance ( methods.cochrane.org/mecir).
• Assessment of risk of bias (MECIR C52 to C60).
• Grading the certainty of the evidence using GRADE (MECIR C74, C75).
• We have amended the inclusion criteria to make it clear that we have excluded trials of multi-component screening that did not
consider the impact of screening on vision outcomes (C40).
• Searches for the 2017 update now include searching the ISRCTN registry, ClinicalTrials.gov and the World Health
Organization (WHO) International Clinical Trials Registry Platform (ICTRP). The UK Clinical Trials Gateway and PubMed are no
longer being searched; (MECIR C27).
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• we compared fixed-effect and random-effects models to test our assumption as to the model required (C71).
We did not do some planned analyses because of lack of data.
• We planned sensitivity analyses to assess the effects of including or excluding trials of different quality. We did not identify any
trials at high risk of bias in any domain so did not do this planned sensitivity analysis.
The protocol specified the odds ratio but we have calculated the risk ratio which is more easily interpreted.
As a result of peer review comments, we performed a post hoc sensitivity analysis excluding studies that did not directly refer patients
to eye specialists.
We also added in a sensitivity analysis for one analysis which included a cluster randomised trial for which we did not have adjusted
estimates.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Mass Screening; Community Health Services; Randomized Controlled Trials as Topic; Vision Disorders [∗prevention & control];
Visual Acuity
MeSH check words
Aged; Humans
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